Grown Rogue International, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA39986R1064
CAD
0.41
0.33 (387.66%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Grown Rogue International, Inc. stock-summary
stock-summary
Grown Rogue International, Inc.
Pharmaceuticals & Biotechnology
Grown Rogue International Inc, formerly Novicius Corp, is a Canada-based company engaged in the alternative medicine sector. The Company is a vertically-integrated cannabis brand that produces and distributes cannabis products. Grown Rogue International Inc specializes in seed-to-experience products through its indoor and outdoor facilities of more than 80,000 square feet, based in Rogue Valley of Southern Oregon, the United States. The Company’s brand offers: Flower, which comes in bags of different sizes together with matchboxes and rolling papers; Pre-rolls, which are nitrogen sealed; Cartridges, as well as Extracts including shatter, wax, oil and sugar that feature concentrated amounts of compounds like tetrahydrocannabinol (THC) and select terpenes.
Company Coordinates stock-summary
Company Details
1 King St W Suite 1505 , TORONTO ON : M5H 1A1
stock-summary
Tel: 1 416 3644039
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.09%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
James Cassina
President, Chief Executive Officer, Director
Mr. Dikshant Batra
Director
Mr. Ritwik Uban
Director
Mr. Colin McNeil
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
8 Million
(Quarterly Results - Jun 2025)
Net Profit:
2 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 130 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.02

stock-summary
Return on Equity

-14.58%

stock-summary
Price to Book

3.46